Via posts strong Q3 results with government demand, major wins, viral adoption, record customers and NRR above 120% driving ...

As of Friday, November 28, ImmunityBio, Inc.’s IBRX share price has surged by 11.03%, which has investors questioning if this is right time to sell.

As of Friday, November 28, Outlook Therapeutics, Inc.’s OTLK share price has surged by 6.55%, which has investors questioning if this is right time to sell.

The Naira posted a stronger performance this week at the official foreign exchange window, trading below the N1,450/$1 threshold for ...

Galicia's weak Q3 loss from margin and HSBC costs with scale intact, deposits and credit up, shares up on macro gains. Learn ...

Netflix finds itself at a pivotal moment as its shares stabilize near $106 after the company's recent 10-for-1 stock split. This apparent calm, however, mask ...

The announcement from Credo Technology Group is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter. It's worth no ...

Betting markets misprice games more often than you think. Discover the data cues and bookmaker errors to spot betting ...

Market expert Raja Venkatraman shares his top three stocks to buy today, 28 November. Discover his exclusive picks and ...

US fresh produce exports remained resilient over the past decade, holding strong through shifting market conditions and ...